Cargando…
Low-value practices in oncology contributing to financial toxicity
Financial toxicity of cancer treatment is now a well-recognised problem in cancer medicine leading to patient bankruptcy and even poor survival, including in high-income countries and countries with public health care systems. Many oncologists, despite acknowledging the severity of financial toxicit...
Autor principal: | Gyawali, Bishal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365336/ https://www.ncbi.nlm.nih.gov/pubmed/28386297 http://dx.doi.org/10.3332/ecancer.2017.727 |
Ejemplares similares
-
Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions
por: Desai, Aakash, et al.
Publicado: (2020) -
Cancer treatment in the last 6 months of life: when inaction can outperform action
por: Gyawali, Bishal, et al.
Publicado: (2018) -
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019) -
What Global Oncology Needs: Mutual Learning and More Funding
por: Gyawali, Bishal, et al.
Publicado: (2018) -
Addressing financial toxicity in oncology care
por: Coughlin, Steven S., et al.
Publicado: (2021)